ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Enjaymo 1100 mg/22 ml, solution pour perfusion - 6 x 22 ml
68074002 Sanofi-Aventis (Suisse) SA
Enjaymo 1100 mg/22 ml, solution pour perfusion21.06.2023
  21.06.2023
(L04AJ04) 
WHO-DDD20.06.2028
6 x 22 ml
07.15. 
A  
No 
IP 
PR  
k.A.PR
  
7680680740026Biotechnologika
  
Composition
sutimlimabum 50 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, polysorbatum 80, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 3.45 mg.
Packungsbestandteile
Infusion solution
 
 
Active AgentDose
Sutimlimabum50 mg/ml
 
Inactive agents
Disodium Phosphate Heptahydrate
Sodium Chloride
Sodium Dihydrogenophosphate Monohydrate
Polysorbatum 80
Source
Data was imported : 08.08.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home